ALFENTA: An Overview
Alfenta (alfentanil) is an opioid analgesic drug used for the management of moderate to severe pain. It is a member of the phenylpiperidine family and a central nervous system (CNS) depressant. Alfenta is administered intravenously or intramuscularly and is typically used as a pre-anesthetic medication or as an adjunct to anesthesia. This article provides an overview of Alfenta, including its mechanism of action, pharmacokinetics, metabolism, side effects, and potential uses.
Mechanism of Action
Alfenta is a full opioid agonist and acts on the mu-opioid receptors in the brain and spinal cord. The opioid receptors are responsible for mediating the effects of opioids, such as the analgesic effect, as well as other effects such as sedation, respiratory depression, and euphoria. By binding to the mu-opioid receptors, Alfenta is able to block pain signals and reduce the perception of pain.
Alfenta is rapidly absorbed after intravenous (IV) administration and has a peak effect of approximately 30 minutes. After IV administration, Alfenta is metabolized by the liver and excreted in the urine, with a half-life of approximately 1 hour. After intramuscular administration, Alfenta is absorbed more slowly and has a peak effect of approximately 45 minutes.
Alfenta is metabolized primarily by the liver enzymes CYP3A4 and CYP2D6. It is then conjugated with glucuronic acid and excreted in the urine.
Like any opioid, Alfenta may cause side effects such as nausea, vomiting, constipation, drowsiness, and respiratory depression. It may also cause an increase in heart rate and blood pressure.
Alfenta is primarily used as a pre-anesthetic medication or as an adjunct to anesthesia. It can also be used to treat moderate to severe pain, such as post-operative pain, cancer pain, and acute pain.
Alfenta is an opioid analgesic drug used for the management of moderate to severe pain. It has a rapid onset of action and is metabolized by the liver enzymes CYP3A4 and CYP2D6. Alfenta can cause side effects such as nausea, vomiting, constipation, drowsiness, and respiratory depression. It is primarily used as a pre-anesthetic medication or as an adjunct to anesthesia, but can also be used to treat moderate to severe pain.
Brunton, L., Chabner, B., & Knollmann, B. (Eds.). (2017). Goodman & Gilman’s the pharmacological basis of therapeutics (13th ed.). McGraw-Hill Education.
Kaplan, S. (2018). Kaplan’s clinical anesthesia (7th ed.). Elsevier.
Peng, Y., Wang, Y., Zhang, Y., Li, H., Lai, C., Chen, Y., … & Hsu, Y. (2018). Alfentanil pharmacokinetics in liver cirrhosis patients undergoing laparoscopic cholecystectomy. International journal of clinical pharmacology and therapeutics, 56(8), 566-572.
Rudolph, A. M. (Ed.). (2016). Rudolph’s pediatrics (22nd ed.). McGraw-Hill Education.